Cargando…
Valproic acid and HIV-1 latency: beyond the sound bite
A recent publication in Lancet by Dr. David Margolis and colleagues raised the prospect that HIV infection may be curable. In this pilot study, which received much attention from the press, Dr. Margolis'group found that valproic acid plus enfuvirtide reduces the pool of CD4(+ )T-cells, which ar...
Autor principal: | Smith, Stephen M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242254/ https://www.ncbi.nlm.nih.gov/pubmed/16168066 http://dx.doi.org/10.1186/1742-4690-2-56 |
Ejemplares similares
-
Lithium and Valproic Acid in Bipolar Disorders and Beyond
por: Scarselli, Marco
Publicado: (2023) -
Relevance of multiply spliced HIV-1 RNA measurement in assessing the efficacy of viral latency-reversing strategies
por: Doria, Margherita
Publicado: (2021) -
Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?
por: Vignesh, Ramachandran, et al.
Publicado: (2017) -
Fatal snake bites – sociodemography, latency pattern of injuries
por: Rao, Chidananda PS, et al.
Publicado: (2013) -
Another one bites the dust…
por: Houghton, Frank
Publicado: (2017)